医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

Adults with Previously Untreated CD30

European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

バイオテクノロジーヘルスケア腫瘍学製薬　 TimeLine: Adults with Previously Untreated CD30 Brentuximab Vedotin European Commission Approves ADCETRIS Stage IV Hodgkin Lymphoma the First New Treatment in Decades for

2019年02月11日